Purchase Order 75N93018P00636
Award Date 4/25/18
Potential Completion Date 4/29/19
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Qlucore Inc., a foreign-owned, for-profit organization, by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services. The contract provides Qlucore's Qlucore Omics Explorer software, including four academic floating licenses (four concurrent users) and one next-generation sequencing (NGS) add-on floating license. The total ceiling value of the contract is $21,860.00, and it is a firm-fixed-price purchase order....
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $13,738.00 on August 23, 2019. The order, firm fixed price with no set-aside, covers Qlucore Omics Explorer software. Performance is located in New York, New York, with completion by August 31, 2020. The purchase order funds software licensing for research and data analysis purposes.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $14,435.00 on June 1, 2018, with completion by August 31, 2019. The order is firm fixed price with no set-aside. Work is performed in New York, New York. The purchase covers Qlucore Ambis software licensing for research data analysis and visualization supporting the institute's infectious disease research mission.</p>
- <p>Qlucore Inc. has been awarded a $23,600 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software. The contract has no set-aside designation and runs through January 23, 2025. Performance will take place in New York, New York to support the National Cancer Institute's research programs.</p>
- <p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $5,549.00 on April 16, 2018, with final completion on May 12, 2018. No set-aside was used. The order covers software licensing—specifically Qlucore Omics Explorer, the vendor's data analysis platform for genomics and cancer research. Performance is at Bethesda, Maryland.</p>
- <p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $4,624.00 on March 13, 2018, with ultimate completion on April 13, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures scientific software licensing, specifically Qlucore Omics Explorer for data visualization and analysis in genomics and cancer research applications.</p>
- This is a $15,641 firm fixed price purchase order contract awarded by the National Eye Institute, a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for a software license and does not have a set-aside designation. Qiagen is a global provider of sample and assay technologies, specialized equipment, and bioinformatics software that supports...
- This is a $13,789.48 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for the provision of QuantiFast probe kits, RNeasy kits, tubes, and caps, which support the agency's biomedical research and public health initiatives. Qiagen has provided similar molecular diagnostics...
- This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to CLC Bio LLC for ADP software. The contract has a ceiling value of $4,995 and was awarded on September 10, 2012, with a scheduled completion date of September 9, 2013. The contract was not set aside for any specific business category. CLC Bio LLC is a foreign-owned, for-profit limited liability company that...